Fortitude Family Office’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.68K Sell
49
-15
-23% -$1.44K ﹤0.01% 1110
2026
Q1
$6.63K Sell
64
-161
-72% -$18.3K ﹤0.01% 815
2025
Q4
$22.7K Buy
225
+186
+477% +$20.2K 0.01% 378
2025
Q3
$4.81K Sell
39
-34
-47% -$4.22K ﹤0.01% 827
2025
Q2
$8.77K Buy
73
+41
+128% +$5.47K ﹤0.01% 596
2025
Q1
$4.71K Hold
32
﹤0.01% 745
2024
Q4
$5.2K Hold
32
﹤0.01% 830
2024
Q3
$5.21K Hold
32
﹤0.01% 778
2024
Q2
$4.37K Hold
32
﹤0.01% 645
2024
Q1
$4.9K Sell
32
-174
-84% -$26K ﹤0.01% 617
2023
Q4
$29.4K Buy
+206
New +$27.5K 0.02% 234

Other funds holding CLX

Fortitude Family Office's CLX Position: Q2 2026 in Review

Fortitude Family Office reduced its Clorox (CLX) stake by 23% in Q2 2026, selling an estimated $1.44K and leaving 49 shares worth $4.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Fortitude Family Office first reported a position in CLX in Q4 2023 and has held it in 11 quarters since. The position peaked at $29.4K in Q4 2023. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Fortitude Family Office held 49 shares of Clorox worth $4.68K as of Q2 2026.
  • Fortitude Family Office sold 15 Clorox shares in Q2 2026, an estimated $1.44K.
  • Clorox made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1110 holding.
  • Fortitude Family Office first reported a position in Clorox in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Clorox position peaked at $29.4K in Q4 2023.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.